265 related articles for article (PubMed ID: 20807772)
1. Dopamine D1-D2 receptor Heteromer-mediated calcium release is desensitized by D1 receptor occupancy with or without signal activation: dual functional regulation by G protein-coupled receptor kinase 2.
Verma V; Hasbi A; O'Dowd BF; George SR
J Biol Chem; 2010 Nov; 285(45):35092-103. PubMed ID: 20807772
[TBL] [Abstract][Full Text] [Related]
2. Desensitization of the dopamine D1 and D2 receptor hetero-oligomer mediated calcium signal by agonist occupancy of either receptor.
So CH; Verma V; O'Dowd BF; George SR
Mol Pharmacol; 2007 Aug; 72(2):450-62. PubMed ID: 17519357
[TBL] [Abstract][Full Text] [Related]
3. Evidence against dopamine D1/D2 receptor heteromers.
Frederick AL; Yano H; Trifilieff P; Vishwasrao HD; Biezonski D; Mészáros J; Urizar E; Sibley DR; Kellendonk C; Sonntag KC; Graham DL; Colbran RJ; Stanwood GD; Javitch JA
Mol Psychiatry; 2015 Nov; 20(11):1373-85. PubMed ID: 25560761
[TBL] [Abstract][Full Text] [Related]
4. Regulation of c-fos expression by the dopamine D1-D2 receptor heteromer.
Perreault ML; Shen MY; Fan T; George SR
Neuroscience; 2015 Jan; 285():194-203. PubMed ID: 25446350
[TBL] [Abstract][Full Text] [Related]
5. D1-D2 dopamine receptor synergy promotes calcium signaling via multiple mechanisms.
Chun LS; Free RB; Doyle TB; Huang XP; Rankin ML; Sibley DR
Mol Pharmacol; 2013 Aug; 84(2):190-200. PubMed ID: 23680635
[TBL] [Abstract][Full Text] [Related]
6. Decreased striatal dopamine efflux after intrastriatal application of benzazepine-class D1 agonists is not mediated via dopamine receptors.
Zackheim JA; Abercrombie ED
Brain Res Bull; 2001 Apr; 54(6):603-7. PubMed ID: 11403986
[TBL] [Abstract][Full Text] [Related]
7. SKF-83959 is not a highly-biased functionally selective D1 dopamine receptor ligand with activity at phospholipase C.
Lee SM; Kant A; Blake D; Murthy V; Boyd K; Wyrick SJ; Mailman RB
Neuropharmacology; 2014 Nov; 86():145-54. PubMed ID: 24929112
[TBL] [Abstract][Full Text] [Related]
8. Reduced striatal dopamine D1-D2 receptor heteromer expression and behavioural subsensitivity in juvenile rats.
Perreault ML; Hasbi A; Alijaniaram M; O'Dowd BF; George SR
Neuroscience; 2012 Dec; 225():130-9. PubMed ID: 22986162
[TBL] [Abstract][Full Text] [Related]
9. A peptide targeting an interaction interface disrupts the dopamine D1-D2 receptor heteromer to block signaling and function in vitro and in vivo: effective selective antagonism.
Hasbi A; Perreault ML; Shen MY; Zhang L; To R; Fan T; Nguyen T; Ji X; O'Dowd BF; George SR
FASEB J; 2014 Nov; 28(11):4806-20. PubMed ID: 25063849
[TBL] [Abstract][Full Text] [Related]
10. Dopamine D1 and D2 receptor Co-activation generates a novel phospholipase C-mediated calcium signal.
Lee SP; So CH; Rashid AJ; Varghese G; Cheng R; Lança AJ; O'Dowd BF; George SR
J Biol Chem; 2004 Aug; 279(34):35671-8. PubMed ID: 15159403
[TBL] [Abstract][Full Text] [Related]
11. D1-D2 dopamine receptor heterooligomers with unique pharmacology are coupled to rapid activation of Gq/11 in the striatum.
Rashid AJ; So CH; Kong MM; Furtak T; El-Ghundi M; Cheng R; O'Dowd BF; George SR
Proc Natl Acad Sci U S A; 2007 Jan; 104(2):654-9. PubMed ID: 17194762
[TBL] [Abstract][Full Text] [Related]
12. Sex difference in dopamine D1-D2 receptor complex expression and signaling affects depression- and anxiety-like behaviors.
Hasbi A; Nguyen T; Rahal H; Manduca JD; Miksys S; Tyndale RF; Madras BK; Perreault ML; George SR
Biol Sex Differ; 2020 Feb; 11(1):8. PubMed ID: 32087746
[TBL] [Abstract][Full Text] [Related]
13. Disruption of a dopamine receptor complex amplifies the actions of cocaine.
Perreault ML; Hasbi A; Shen MYF; Fan T; Navarro G; Fletcher PJ; Franco R; Lanciego JL; George SR
Eur Neuropsychopharmacol; 2016 Sep; 26(9):1366-1377. PubMed ID: 27480020
[TBL] [Abstract][Full Text] [Related]
14. The dopamine D1-D2 receptor heteromer exerts a tonic inhibitory effect on the expression of amphetamine-induced locomotor sensitization.
Shen MY; Perreault ML; Fan T; George SR
Pharmacol Biochem Behav; 2015 Jan; 128():33-40. PubMed ID: 25444866
[TBL] [Abstract][Full Text] [Related]
15. Activation of D1 and D2 dopamine receptors increases the activity of the somatostatin receptor-effector system in the rat frontoparietal cortex.
Izquierdo-Claros RM; del Boyano-Adánez M; Arilla-Ferreiro E
J Neurosci Res; 2000 Oct; 62(1):91-8. PubMed ID: 11002291
[TBL] [Abstract][Full Text] [Related]
16. The atypical dopamine D1 receptor agonist SKF 83959 induces striatal Fos expression in rats.
Wirtshafter D; Osborn CV
Eur J Pharmacol; 2005 Dec; 528(1-3):88-94. PubMed ID: 16324697
[TBL] [Abstract][Full Text] [Related]
17. Prior D1 dopamine receptor stimulation is required to prime D2-mediated striatal Fos expression in 6-hydroxydopamine-lesioned rats.
Pollack AE; Yates TM
Neuroscience; 1999; 94(2):505-14. PubMed ID: 10579212
[TBL] [Abstract][Full Text] [Related]
18. Repeated stimulation of D1 dopamine receptors causes time-dependent alterations in the sensitivity of both D1 and D2 dopamine receptors within the rat striatum.
Hu XT; Brooderson RJ; White FJ
Neuroscience; 1992 Sep; 50(1):137-47. PubMed ID: 1357592
[TBL] [Abstract][Full Text] [Related]
19. Dopaminergic inhibition of catecholamine secretion from chromaffin cells: evidence that inhibition is mediated by D4 and D5 dopamine receptors.
Dahmer MK; Senogles SE
J Neurochem; 1996 Jan; 66(1):222-32. PubMed ID: 8522958
[TBL] [Abstract][Full Text] [Related]
20. Dopamine receptor agonist reduces ethanol self-administration in the ethanol-preferring C57BL/6J inbred mouse.
Ng GY; George SR
Eur J Pharmacol; 1994 Nov; 269(3):365-74. PubMed ID: 7895775
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
